John K Erban Selected Research

John K Erban Research Topics

Disease

12	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2002
3	Neoplasms (Cancer) 08/2019 - 03/2011
2	Amenorrhea 03/2011 - 06/2010
2	Hemorrhage 02/2003 - 03/2002
1	Chronic Pain 12/2020
1	Mood Disorders (Mood Disorder) 12/2020
1	Triple Negative Breast Neoplasms 08/2019
1	Prediabetic State (Prediabetes) 01/2019
1	Cardiotoxicity 01/2019
1	Overweight 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Heart Failure 01/2019
1	Eosinophilia 01/2017
1	Embolic Stroke 01/2017
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2017
1	Lung Diseases (Lung Disease) 12/2014
1	Pulmonary Alveolar Proteinosis 12/2014
1	Respiratory Insufficiency (Respiratory Failure) 12/2014
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2014
1	Hematologic Neoplasms (Hematological Malignancy) 12/2014
1	Febrile Neutropenia 04/2007
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2007
1	Hemolytic Anemia 01/2007
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2007
1	Hemolysis 01/2007
1	Anemia 01/2007
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2007
1	Fever (Fevers) 02/2006
1	Constipation 02/2006
1	Neutropenia 02/2006
1	Carcinoid Tumor (Carcinoid) 01/2004
1	Liver Diseases (Liver Disease) 02/2003
1	Endometrial Neoplasms (Endometrial Cancer) 09/2002
1	Thrombophilia 03/2002
1	Venous Thromboembolism 03/2002

Drug/Important Bio-Agent (IBA)

4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 02/2006
3	Tamoxifen FDA LinkGeneric 03/2011 - 09/2002
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2010 - 02/2006
3	Docetaxel (Taxotere)FDA Link 06/2010 - 02/2006
2	Hormones (Hormone)IBA 12/2020 - 03/2011
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 04/2007
2	AnthracyclinesIBA 01/2019 - 06/2010
2	Rituximab (Mabthera)FDA Link 12/2014 - 01/2007
2	QuinolonesIBA 04/2007 - 02/2006
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2007 - 02/2006
2	Vinorelbine (Navelbine)FDA LinkGeneric 04/2007 - 02/2006
2	factor V LeidenIBA 02/2003 - 03/2002
2	AnticoagulantsIBA 02/2003 - 03/2002
1	Poly Adenosine Diphosphate RiboseIBA 08/2019
1	pembrolizumabIBA 08/2019
1	niraparibIBA 08/2019
1	antineoplaston A10 (A 10)IBA 01/2019
1	taxaneIBA 01/2019
1	Biological ProductsIBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	apixabanIBA 01/2017
1	TroponinIBA 01/2017
1	Prednisone (Sone)FDA LinkGeneric 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2014
1	Bendamustine Hydrochloride FDA Link 12/2014
1	AntibodiesIBA 12/2014
1	LipidsIBA 12/2014
1	Proteins (Proteins, Gene)FDA Link 12/2014
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 12/2014
1	Surface-Active Agents (Surfactants)IBA 12/2014
1	Taxoids (Taxanes)IBA 06/2010
1	Estrogen ReceptorsIBA 06/2010
1	Trastuzumab (Herceptin)FDA Link 04/2007
1	human ERBB2 proteinIBA 04/2007
1	SteroidsIBA 01/2007
1	Letrozole (Femara)FDA LinkGeneric 04/2006
1	LaxativesIBA 02/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2006
1	Interferon-gamma (Interferon, gamma)IBA 01/2004
1	Prothrombin (Factor II)IBA 03/2002

Therapy/Procedure

6	Therapeutics 12/2020 - 03/2002
4	Drug Therapy (Chemotherapy) 01/2019 - 08/2006
3	Neoadjuvant Therapy 02/2017 - 02/2006
2	Adjuvant Chemotherapy 01/2021 - 03/2011
1	Secondary Prevention 12/2020
1	Treatment Delay 01/2020
1	Liver Transplantation 01/2007
1	Preoperative Care 02/2003
1	Aftercare (After-Treatment) 09/2002